ZKGIDPONSMVZPC-ZWKOTPCHSA-N
C26H33F3N4O9S — CID 122638105
Data last refreshed: (MolForge compound catalog, from PubChem)
About ZKGIDPONSMVZPC-ZWKOTPCHSA-N
ZKGIDPONSMVZPC-ZWKOTPCHSA-N (PubChem CID 122638105) has the molecular formula C26H33F3N4O9S and a molecular weight of 634.63 g/mol. Its IUPAC name is (2R)-2-cyclopropyl-3-[(2S)-4-[1-ethyl-3-(2-hydroxyethoxy)pyrazol-4-yl]sulfonyl-6-[(1,1,1-trifluoro-2-methylpropan-2-yl)oxycarbonylamino]-2,3-dihydro-1,4-benzoxazin-2-yl]propanoic acid.
Molecular Properties
| Compound Name | ZKGIDPONSMVZPC-ZWKOTPCHSA-N |
|---|---|
| PubChem CID | 122638105 |
| Molecular Formula | C26H33F3N4O9S |
| Molecular Weight | 634.63 g/mol |
| Exact Mass | 634.19 |
| IUPAC Name | (2R)-2-cyclopropyl-3-[(2S)-4-[1-ethyl-3-(2-hydroxyethoxy)pyrazol-4-yl]sulfonyl-6-[(1,1,1-trifluoro-2-methylpropan-2-yl)oxycarbonylamino]-2,3-dihydro-1,4-benzoxazin-2-yl]propanoic acid |
| SMILES | CCn1cc(S(=O)(=O)N2C[C@H](C[C@@H](C(=O)O)C3CC3)Oc3ccc(NC(=O)OC(C)(C)C(F)(F)F)cc32)c(OCCO)n1 |
| InChI | InChI=1S/C26H33F3N4O9S/c1-4-32-14-21(22(31-32)40-10-9-34)43(38,39)33-13-17(12-18(23(35)36)15-5-6-15)41-20-8-7-16(11-19(20)33)30-24(37)42-25(2,3)26(27,28)29/h7-8,11,14-15,17-18,34H,4-6,9-10,12-13H2,1-3H3,(H,30,37)(H,35,36)/t17-,18+/m0/s1 |
| InChIKey | ZKGIDPONSMVZPC-ZWKOTPCHSA-N |
| XLogP | 3.62 |
| TPSA | 169.52 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 634.63 |
| LogP ≤ 5 | 3.62 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122638105 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.